These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Structure, regulation, and (patho-)physiological functions of the stress-induced protein kinase CK1 delta (CSNK1D). Xu P; Ianes C; Gärtner F; Liu C; Burster T; Bakulev V; Rachidi N; Knippschild U; Bischof J Gene; 2019 Oct; 715():144005. PubMed ID: 31376410 [TBL] [Abstract][Full Text] [Related]
10. CK1δ activity is modulated by CDK2/E- and CDK5/p35-mediated phosphorylation. Ianes C; Xu P; Werz N; Meng Z; Henne-Bruns D; Bischof J; Knippschild U Amino Acids; 2016 Feb; 48(2):579-92. PubMed ID: 26464264 [TBL] [Abstract][Full Text] [Related]
11. Casein Kinase 1δ Inhibitors as Promising Therapeutic Agents for Neurodegenerative Disorders. Catarzi D; Varano F; Vigiani E; Lambertucci C; Spinaci A; Volpini R; Colotta V Curr Med Chem; 2022; 29(27):4698-4737. PubMed ID: 35232339 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of gamma-secretase by the CK1 inhibitor IC261 does not depend on CK1delta. Höttecke N; Liebeck M; Baumann K; Schubenel R; Winkler E; Steiner H; Schmidt B Bioorg Med Chem Lett; 2010 May; 20(9):2958-63. PubMed ID: 20350806 [TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of CK1delta: identification of Ser370 as the major phosphorylation site targeted by PKA in vitro and in vivo. Giamas G; Hirner H; Shoshiashvili L; Grothey A; Gessert S; Kühl M; Henne-Bruns D; Vorgias CE; Knippschild U Biochem J; 2007 Sep; 406(3):389-98. PubMed ID: 17594292 [TBL] [Abstract][Full Text] [Related]
14. Developing novel classes of protein kinase CK1δ inhibitors by fusing [1,2,4]triazole with different bicyclic heteroaromatic systems. Grieco I; Bissaro M; Tiz DB; Perez DI; Perez C; Martinez A; Redenti S; Mariotto E; Bortolozzi R; Viola G; Cozza G; Spalluto G; Moro S; Federico S Eur J Med Chem; 2021 Apr; 216():113331. PubMed ID: 33721670 [TBL] [Abstract][Full Text] [Related]
15. Therapeutic targeting of casein kinase 1δ in breast cancer. Rosenberg LH; Lafitte M; Quereda V; Grant W; Chen W; Bibian M; Noguchi Y; Fallahi M; Yang C; Chang JC; Roush WR; Cleveland JL; Duckett DR Sci Transl Med; 2015 Dec; 7(318):318ra202. PubMed ID: 26676609 [TBL] [Abstract][Full Text] [Related]
16. Zebrafish as model system for the biological characterization of CK1 inhibitors. Meier L; Gahr BM; Roth A; Gihring A; Kirschner S; Woitaske-Proske C; Baier J; Peifer C; Just S; Knippschild U Front Pharmacol; 2023; 14():1245246. PubMed ID: 37753113 [No Abstract] [Full Text] [Related]
17. 3,4-Diaryl-isoxazoles and -imidazoles as potent dual inhibitors of p38alpha mitogen activated protein kinase and casein kinase 1delta. Peifer C; Abadleh M; Bischof J; Hauser D; Schattel V; Hirner H; Knippschild U; Laufer S J Med Chem; 2009 Dec; 52(23):7618-30. PubMed ID: 19591487 [TBL] [Abstract][Full Text] [Related]
18. Interaction of casein kinase 1 delta (CK1 delta) with the light chain LC2 of microtubule associated protein 1A (MAP1A). Wolff S; Xiao Z; Wittau M; Süssner N; Stöter M; Knippschild U Biochim Biophys Acta; 2005 Sep; 1745(2):196-206. PubMed ID: 15961172 [TBL] [Abstract][Full Text] [Related]
19. A Computational Workflow for the Identification of Novel Fragments Acting as Inhibitors of the Activity of Protein Kinase CK1δ. Bolcato G; Cescon E; Pavan M; Bissaro M; Bassani D; Federico S; Spalluto G; Sturlese M; Moro S Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575906 [TBL] [Abstract][Full Text] [Related]
20. Relationship between a point mutation S97C in CK1δ protein and its affect on ATP-binding affinity. Kumar A; Rajendran V; Sethumadhavan R; Purohit R J Biomol Struct Dyn; 2014; 32(3):394-405. PubMed ID: 23527964 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]